| NTRA |
Natera, Inc. |
0 |
5.86% |
|
|
|
|
|
N/A |
0.00% |
53.38% |
31.33% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
5.41% |
|
|
|
|
|
N/A |
0.00% |
74.15% |
18.96% |
|---|
| QGEN |
Qiagen N.V. |
0 |
4.66% |
|
|
|
|
|
N/A |
0.00% |
125.33% |
14.79% |
|---|
| TECH |
Bio-Techne Corporation |
0 |
4.57% |
|
|
|
|
|
N/A |
0.00% |
55.87% |
64.27% |
|---|
| BNTX |
BioNTech SE |
0 |
4.45% |
|
|
|
|
|
N/A |
0.00% |
43.87% |
30.54% |
|---|
| A |
Agilent Technologies, Inc. |
0 |
4.42% |
|
|
|
|
|
N/A |
0.00% |
34.00% |
34.36% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
4.10% |
|
|
|
|
|
N/A |
0.00% |
39.49% |
50.37% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
4.10% |
|
|
|
|
|
N/A |
0.00% |
75.44% |
34.69% |
|---|
| ILMN |
Illumina, Inc. |
0 |
4.09% |
|
|
|
|
|
N/A |
0.00% |
39.56% |
23.84% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
4.09% |
|
|
|
|
|
N/A |
0.00% |
117.60% |
53.76% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
3.76% |
|
|
|
|
|
N/A |
0.00% |
66.94% |
41.18% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
3.68% |
|
|
|
|
|
N/A |
0.00% |
57.68% |
34.39% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
3.51% |
|
|
|
|
|
N/A |
0.00% |
33.44% |
22.47% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
3.39% |
|
|
|
|
|
N/A |
0.00% |
57.42% |
15.18% |
|---|
| LEGN |
Legend Biotech Corporation |
0 |
3.27% |
|
|
|
|
|
N/A |
0.00% |
49.87% |
20.04% |
|---|
| MRNA |
Moderna, Inc. |
0 |
3.23% |
|
|
|
|
|
N/A |
0.00% |
56.54% |
10.47% |
|---|
| TXG |
10x Genomics, Inc. |
0 |
2.97% |
|
|
|
|
|
N/A |
0.00% |
73.82% |
22.84% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
2.82% |
|
|
|
|
|
N/A |
0.00% |
107.70% |
69.67% |
|---|
| 1548.HK |
GENSCRIPT BIOTECH CORP |
|
2.76% |
|
|
|
|
|
|
|
|
|
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
2.47% |
|
|
|
|
|
N/A |
0.00% |
809.33% |
102.56% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
2.36% |
|
|
|
|
|
N/A |
0.00% |
92.06% |
42.42% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
2.31% |
|
|
|
|
|
N/A |
0.00% |
29.35% |
27.52% |
|---|
| CDNA |
CareDx, Inc |
0 |
2.17% |
|
|
|
|
|
N/A |
0.00% |
99.20% |
49.73% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
2.09% |
|
|
|
|
|
N/A |
0.00% |
173.45% |
70.73% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
1.87% |
|
|
|
|
|
N/A |
0.00% |
35.91% |
45.64% |
|---|
| QURE |
uniQure N.V. |
0 |
1.59% |
|
|
|
|
|
N/A |
0.00% |
69.24% |
46.38% |
|---|
| VIR |
Vir Biotechnology, Inc. |
0 |
1.34% |
|
|
|
|
|
N/A |
0.00% |
379.77% |
49.42% |
|---|
| MRVI |
Maravai LifeSciences Holdings, Inc. |
0 |
1.33% |
|
|
|
|
|
N/A |
0.00% |
975.17% |
58.42% |
|---|
| PSTX |
POSEIDA THERAPEUTICS INC |
|
1.26% |
|
|
|
|
|
|
|
|
|
|---|
| SGMO |
Sangamo Therapeutics, Inc. |
0 |
0.96% |
|
|
|
|
|
N/A |
0.00% |
257.23% |
48.99% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
454.42% |
41.52% |
|---|
| FLGT |
Fulgent Genetics, Inc. |
0 |
0.75% |
|
|
|
|
|
N/A |
0.00% |
48.17% |
30.77% |
|---|
| VERV |
Verve Therapeutics, Inc. |
0 |
0.71% |
|
|
|
|
|
N/A |
0.00% |
184.40% |
3.87% |
|---|
| RGNX |
REGENXBIO Inc. |
0 |
0.66% |
|
|
|
|
|
N/A |
0.00% |
1,209.59% |
17.85% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
175.10% |
84.73% |
|---|
| SANA |
Sana Biotechnology, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
222.71% |
53.02% |
|---|
| TSVT |
2SEVENTY BIO INC |
|
0.29% |
|
|
|
|
|
|
|
|
|
|---|
| CRBU |
Caribou Biosciences, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
260.93% |
26.13% |
|---|
| EDIT |
Editas Medicine, Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
147.29% |
50.55% |
|---|
| LYEL |
Lyell Immunopharma, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
891.47% |
1.73% |
|---|
| E |
Eni S.p.A. |
0 |
0.01% |
|
|
|
|
|
N/A |
0.00% |
67.51% |
35.09% |
|---|